Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07430293
Eligibility Criteria:
Inclusion Criteria:
1. Age from 18 years
2. History of total or partial pancreatectomy with random C-peptide \< 0.3 ng/mL and concomitant blood glucose between 120 and 225 mg/dL (no minimum delay required since surgery)
3. Total daily insulin dose between 6 units and 250 units
4. Be affiliated to a French social security scheme
5. Individual able and willing to provide written informed consent
Exclusion Criteria:
1. Presence of diabetic retinopathy at or beyond severe non-proliferative diabetic retinopathy, not stabilized by ophthalmologic treatment
2. Usual diabetes treatment with an insulin pump coupled with continuous glucose monitoring with a "suspend before hypoglycemia" system
3. Pregnant woman or planned pregnancy within the next 6 months
4. Planned chemotherapy within the next 6 months
5. Enteral or parenteral nutrition
6. Estimated life expectancy less than 12 months
7. Cognitive or psychiatric disorders compromising the individual's autonomy to manage automated insulin delivery
8. Person taking part in another research study or with an exclusion period still in progress
9. Individual under legal guardianship or curatorship
10. Any contraindication mentioned in the instructions for use of the MiniMed 780 - Simplera
11. Imprisoned or otherwise deprived of liberty
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07430293
Study Brief:
Protocol Section:
NCT07430293